Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples